BORDER LINES: Lobbyists target drug review

SYDNEY: The rules which prevent drug companies promoting their products directly to consumers are set to be relaxed under recommendations from a review of the laws. The review, commissioned by the Committee of Australian Governments, has attracted intense lobbying from both the pharmaceutical industry, which wants the rules relaxed, and consumer groups, who want the tight rules to stay. ’We do want information to be much more available to consumers about medicine,’ said chair of the review, Rhonda Galbally.

SYDNEY: The rules which prevent drug companies promoting their

products directly to consumers are set to be relaxed under

recommendations from a review of the laws. The review, commissioned by

the Committee of Australian Governments, has attracted intense lobbying

from both the pharmaceutical industry, which wants the rules relaxed,

and consumer groups, who want the tight rules to stay. ’We do want

information to be much more available to consumers about medicine,’ said

chair of the review, Rhonda Galbally.



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.